{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:04:57Z","timestamp":1792839897571,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R38AI140297"],"award-info":[{"award-number":["1R38AI140297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014228","name":"Duke Cancer Institute","doi-asserted-by":"crossref","award":["P30 CA014236"],"award-info":[{"award-number":["P30 CA014236"]}],"id":[{"id":"10.13039\/100014228","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1245\/s10434-023-13872-y","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T13:01:53Z","timestamp":1689166913000},"page":"6639-6646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7758-3545","authenticated-orcid":false,"given":"Sabran J.","family":"Masoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Rhodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elishama","family":"Kanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin M.","family":"Eckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berk","family":"Aykut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliann E.","family":"Kosovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Palta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Befera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Dan G.","family":"Blazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Zani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Lidsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"issue":"5","key":"13872_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist. 2016;21(5):594\u20139.","journal-title":"Oncologist."},{"issue":"2","key":"13872_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/13651820801992641","volume":"10","author":"S Khan","year":"2008","unstructured":"Khan S, Toledano M, Taylor-Robinson S. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):77\u201382.","journal-title":"HPB (Oxford)."},{"issue":"2","key":"13872_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.soc.2013.10.004","volume":"23","author":"KM Brown","year":"2014","unstructured":"Brown KM, Parmar AD, Geller DA. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2014;23(2):231\u201346.","journal-title":"Surg Oncol Clin N Am."},{"issue":"1","key":"13872_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84\u201396.","journal-title":"Ann Surg."},{"issue":"3","key":"13872_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00000658-199809000-00011","volume":"228","author":"EC Burke","year":"1998","unstructured":"Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228(3):385\u201394.","journal-title":"Ann Surg."},{"key":"13872_CR6","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Hepatobiliary cancers, version 4; 2022. National Comprehensive Cancer Network Website. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf. 2022."},{"issue":"5","key":"13872_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(5):541\u201365.","journal-title":"J Natl Compr Canc Netw."},{"issue":"3","key":"13872_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000521665","volume":"11","author":"T Takayama","year":"2022","unstructured":"Takayama T, Hasegawa K, Izumi N, Kudo M, Shimada M, Yamanaka N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2022;11(3):209\u201318.","journal-title":"Liver Cancer."},{"issue":"2","key":"13872_CR9","doi-asserted-by":"publisher","first-page":"W205","DOI":"10.2214\/AJR.10.4937","volume":"196","author":"JH Kim","year":"2011","unstructured":"Kim JH, Won HJ, Shin YM, Kim KA, Kim PN. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol. 2011;196(2):W205-209.","journal-title":"AJR Am J Roentgenol."},{"issue":"3","key":"13872_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.21037\/jgo.2018.02.04","volume":"9","author":"AR Kolarich","year":"2018","unstructured":"Kolarich AR, Shah JL, George TJ Jr, Hughes SJ, Shaw CM, Geller BS, et al. Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004\u20132015: an NCDB analysis. J Gastrointest Oncol. 2018;9(3):536\u201345.","journal-title":"J Gastrointest Oncol."},{"key":"13872_CR11","doi-asserted-by":"crossref","unstructured":"Xiang X, Hu D, Jin Z, Liu P, Lin H. Radiofrequency ablation vs. surgical resection for small early-stage primary intrahepatic cholangiocarcinoma. Front Oncol. 2020;10:540662.","DOI":"10.3389\/fonc.2020.540662"},{"issue":"4","key":"13872_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","volume":"26","author":"RV Tse","year":"2008","unstructured":"Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2008;26(4):657\u201364.","journal-title":"J Clin Oncol."},{"issue":"10","key":"13872_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/1471-2407-10-492","volume":"14","author":"YX Chen","year":"2010","unstructured":"Chen YX, Zeng ZC, Tang ZY, Fan J, Zhou J, Jiang W, et al. Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients. BMC Cancer. 2010;14(10):492.","journal-title":"BMC Cancer."},{"issue":"5","key":"13872_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","volume":"34","author":"TS Hong","year":"2016","unstructured":"Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, et al. Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2016;34(5):460\u20138.","journal-title":"J Clin Oncol."},{"issue":"55","key":"13872_CR15","doi-asserted-by":"publisher","first-page":"93541","DOI":"10.18632\/oncotarget.19972","volume":"8","author":"ZT Shen","year":"2017","unstructured":"Shen ZT, Zhou H, Li AM, Li B, Shen JS, Zhu XX. Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma. Oncotarget. 2017;8(55):93541\u201350.","journal-title":"Oncotarget."},{"issue":"6","key":"13872_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jceh.2019.08.001","volume":"9","author":"A Yousaf","year":"2019","unstructured":"Yousaf A, Kim JU, Eliahoo J, Taylor-Robinson SD, Khan SA. Ablative therapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Clin Exp Hepatol. 2019;9(6):740\u20138.","journal-title":"J Clin Exp Hepatol."},{"issue":"8","key":"13872_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/jso.21173","volume":"99","author":"MV Raval","year":"2009","unstructured":"Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009;99(8):488\u201390.","journal-title":"J Surg Oncol."},{"issue":"12","key":"13872_CR18","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, et al. Using the national cancer database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722\u20138.","journal-title":"JAMA Oncol."},{"issue":"4","key":"13872_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5604\/01.3001.0012.0929","volume":"17","author":"SO Antwi","year":"2018","unstructured":"Antwi SO, Mousa OY, Patel T. Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995\u20132014. Ann Hepatol. 2018;17(4):604\u201314.","journal-title":"Ann Hepatol."},{"issue":"2","key":"13872_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.21037\/jgo.2018.12.07","volume":"10","author":"E Ransome","year":"2019","unstructured":"Ransome E, Tong L, Espinosa J, Chou J, Somnay V, Munene G. Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005\u20132014. J Gastrointest Oncol. 2019;10(2):339\u201347.","journal-title":"J Gastrointest Oncol."},{"issue":"13","key":"13872_CR21","doi-asserted-by":"publisher","first-page":"8162","DOI":"10.1245\/s10434-021-10202-y","volume":"28","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Dalmacy D, Hyer JM, Diaz A, Abbas A, Pawlik TM. Disparities in NCCN guideline compliant care for resectable cholangiocarcinoma at minority-serving versus non-minority-serving hospitals. Ann Surg Oncol. 2021;28(13):8162\u201371.","journal-title":"Ann Surg Oncol."},{"key":"13872_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102258","volume":"99","author":"J Edeline","year":"2021","unstructured":"Edeline J, Lamarca A, McNamara MG, Jacobs T, Hubner RA, Palmer D, et al. Locoregional therapies in patients with intrahepatic cholangiocarcinoma: a systematic review and pooled analysis. Cancer Treat Rev. 2021;99:102258.","journal-title":"Cancer Treat Rev."},{"issue":"5","key":"13872_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373.","journal-title":"Lancet Oncol."},{"key":"13872_CR24","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1245\/s10434-023-13567-4","volume":"30","author":"KE Rhodin","year":"2023","unstructured":"Rhodin KE, Liu A, Bartholomew A, Kramer R, Parameswaran A, Uronis H, et al. Trends in receipt of adjuvant chemotherapy and its impact on survival in resected biliary tract cancers. Ann Surg Oncol. 2023;30:4813\u201321.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"13872_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21037\/hbsn.2017.01.16","volume":"6","author":"EJ Koay","year":"2017","unstructured":"Koay EJ, Odisio BC, Javle M, Vauthey JN, Crane CH. Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments? Hepatobiliary Surg Nutr. 2017;6(2):105\u201316.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"23","key":"13872_CR26","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.3390\/cancers14235853","volume":"14","author":"AE Hare","year":"2022","unstructured":"Hare AE, Makary MS. Locoregional approaches in cholangiocarcinoma treatment. Cancers (Basel). 2022;14(23):5853.","journal-title":"Cancers (Basel)."},{"issue":"4","key":"13872_CR27","first-page":"287","volume":"7","author":"A Giorgio","year":"2019","unstructured":"Giorgio A, Gatti P, Montesarchio L, Santoro B, Dell\u2019Olio A, Crucinio N, et al. Intrahepatic cholangiocarcinoma and thermal ablation: long-term results of an Italian retrospective multicenter study. J Clin Transl Hepatol. 2019;7(4):287\u201392.","journal-title":"J Clin Transl Hepatol."},{"issue":"8","key":"13872_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","volume":"24","author":"S Mouli","year":"2013","unstructured":"Mouli S, Memon K, Baker T, Benson AB 3rd, Mulcahy MF, Gupta R, et al. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013;24(8):1227\u201334.","journal-title":"J Vasc Interv Radiol."},{"issue":"4","key":"13872_CR29","first-page":"437","volume":"24","author":"JB Kuhlmann","year":"2012","unstructured":"Kuhlmann JB, Euringer W, Spangenberg HC, Breidert M, Blum HE, Harder J, et al. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. Eur J Gastroenterol Hepatol. 2012;24(4):437\u201343.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"3","key":"13872_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","volume":"34","author":"R Tao","year":"2016","unstructured":"Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, et al. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis. J Clin Oncol. 2016;34(3):219\u201326.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13872-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13872-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13872-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:05:49Z","timestamp":1695045949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13872-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["13872"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13872-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Oral presentation, Society of Surgical Oncology Advanced Cancer Therapies 2023, San Diego, CA, 18 February 2023","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}